Health ❯ Healthcare

Chronic Diseases

Diabetes Obesity Type 2 Diabetes Heart Disease Kidney Disease Hypertension Cardiovascular Disease Cardiovascular Diseases Cancer Cardiovascular Health

EMA Panel Backs Higher 7.2 mg Wegovy Dose for Obesity

A European Commission ruling will determine EU availability next.

Meta-Analysis Finds GLP-1 Drugs Show Little Short-Term Impact on Obesity-Linked Cancer Risk

Study Maps Alzheimer’s Hotspots in Rural Maryland With High Deaths, Low Diagnoses

Ianalumab Plus Eltrombopag Extends Disease Control in Phase 3 ITP Study Published in NEJM

WHO Endorses Long-Term GLP-1 Use for Obesity as Indian Ruling Opens Production and Safety Alerts Expand

New HIV Remission Case and Immunotherapy Trial Signal Immune-Based Paths Off ART

Monthly Tezepelumab Shot Lets Over Half With Severe Asthma Stop Daily Steroids, International Trial Finds

Novo Nordisk’s Oral Semaglutide Fails to Slow Alzheimer’s in Dual Phase 3 Trials

Antimicrobial Resistance Deepens as Experts Urge Smarter Prescribing and Non‑Antibiotic Care

AGA Overhauls Crohn’s Treatment With Living Guideline Favoring Early High‑Efficacy Therapies

EU Medicines Panel Backs Teizeild to Delay Type 1 Diabetes Onset

WHO Warning Rekindles Global Drive To Prevent Deadly Pneumonia

Cohort Connect 2025 Showcases Phenome India, a National Health Cohort and Biobank

Half of Indians Tested Show Abnormal Blood Sugar, PharmEasy Analysis Warns

Randomized Trial Finds Metformin Dulls Key Gains From Exercise

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro

Russia Probes Reports of CGM Sensor Shortfalls as Regions Deny Gaps

Real-World Study Finds Semaglutide and Tirzepatide Cut Cardiovascular Risk in Type 2 Diabetes

JAMA Meta-Analyses at Kidney Week Back Routine SGLT2 Inhibitors Across Kidney Function

Repatha Cuts First Major Cardiac Events by 25% in At-Risk Adults in AHA Trial